CD44 and glioma: Binding of stimulants to CD44 results in activation of intracellular cascade, activation of growth regulation pathways, and suppression of tumor suppressor pathways that results in increased cell division, resistance against chemotherapeutic agents, and invasion of glioma cells to normal healthy cells.